Top Markets
Coin of the day
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
Rang in aandelen #25549
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
Aandeelprijs
$20.01
Laatst gesynchroniseerd: 2025-02-21
Marktkapitalisatie
$48.36M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Singular Genomics Systems, Inc. (OMIC)

Categorie

Winst voor Singular Genomics Systems, Inc. (OMIC)
Winst in Sep 2024 TTM: $-86.32M
Volgens de meest recente financiële verslagen van Singular Genomics Systems, Inc. bedraagt de huidige winst van het bedrijf $-86.32M. In 2022 behaalde het bedrijf een winst van $-90.88M, een stijging ten opzichte van de winst van 2021, die $-98.77M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Singular Genomics Systems, Inc. van 2019 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-86.32M -8.96%
2023 $-94.82M 4.34%
2022 $-90.88M -7.99%
2021 $-98.77M 253.45%
2020 $-27.95M 126.75%
2019 $-12.32M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$3.81B -4,508.84%
US
$4.11B -4,859.90%
FR
- -
JP
$1.59B -1,941.94%
US
- -
CH